|
TMOD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.448500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.592910E-04 |
| Normal-vs-Stage2 |
7.581600E-01 |
| Normal-vs-Stage3 |
7.819900E-03 |
| Normal-vs-Stage4 |
4.824100E-02 |
| Stage1-vs-Stage2 |
2.078700E-03 |
| Stage1-vs-Stage3 |
8.526800E-01 |
| Stage1-vs-Stage4 |
7.552200E-01 |
| Stage2-vs-Stage3 |
1.395870E-02 |
| Stage2-vs-Stage4 |
5.012100E-02 |
| Stage3-vs-Stage4 |
8.804800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58430000000354E-05 |
| Normal-vs-AfricanAmerican |
7.917700E-02 |
| Normal-vs-Asian |
5.241800E-02 |
| Caucasian-vs-AfricanAmerican |
9.523000E-01 |
| Caucasian-vs-Asian |
7.557800E-01 |
| AfricanAmerican-vs-Asian |
8.804800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.060100E-03 |
| Normal-vs-Female |
4.405300E-04 |
| Male-vs-Female |
9.287600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92868999999707E-05 |
| Normal-vs-Age(41-60Yrs) |
1.770000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.742400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.087000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.381800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.599350E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.817200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.036800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.843000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.248000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.068800E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
3.968400E-01 |
| Classical-VS-Normal |
2.20410000029148E-07 |
| Tall-VS-Follicular |
2.10229999999534E-05 |
| Tall-VS-Other |
2.523600E-01 |
| Tall-VS-Normal |
1.981000E-03 |
| Follicular-VS-Other |
2.843400E-01 |
| Follicular-VS-Normal |
5.556600E-03 |
| Other-VS-Normal |
6.803800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.184000E-01 |
| Normal-vs-N1 |
1.475510E-02 |
| N0-vs-N1 |
5.238200E-02 |
|
|
